Shika H. Malgundkar

Muscat, MA, Oman

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Malformin A1-mediated cytotoxicity in ovarian cancer cells occurs through pyroptosis and autophagy.

Malformin A1-mediated cytotoxicity in ovarian cancer cells occurs through pyroptosis and autophagy.

Journal: FEBS open bio

Published: February 06, 2026

The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC).

The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC).

Journal: Human genetics

Published: June 15, 2023

Epigenetic status of FBXW7 gene and its role in Ovarian cancer pathogenesis.

Epigenetic status of FBXW7 gene and its role in Ovarian cancer pathogenesis.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: October 18, 2022

Identification and validation of a novel long non-coding RNA (LINC01465) in ovarian cancer.

Identification and validation of a novel long non-coding RNA (LINC01465) in ovarian cancer.

Journal: Human cell

Published: June 30, 2022

Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer.

Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer.

Journal: Future science OA

Published: June 09, 2022

SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer.

SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer.

Journal: Human cell

Published: January 13, 2022

E2F5 Promotes the Malignancy of Ovarian Cancer Via the Regulation of Hippo and Wnt Pathways.

E2F5 Promotes the Malignancy of Ovarian Cancer Via the Regulation of Hippo and Wnt Pathways.

Journal: Genetic testing and molecular biomarkers

Published: March 18, 2021

FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.

FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.

Journal: BMC cancer

Published: November 25, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026